KilgoreKP, LeeMS, LeavittJA, et al.Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology, 2017; 124(5):697–700.
2.
WitryM, KindlerC, WellerJ, et al.The patients' perspective on the burden of idiopathic intracranial hypertension. J Headache Pain, 2021; 22(1):1–6.
3.
KilgoreKP, LeeMS, LeavittJA, et al.A population-based, case-control evaluation of the association between hormonal contraceptives and idiopathic intracranial hypertension. Am J Ophthalmol, 2019; 197:74–79.
4.
BiousseV, BruceBB, NewmanNJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry, 2012; 83(5):488–494.
5.
WestgateCS, BotfieldHF, AlimajstorovicZ, et al.Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight, 2021; 6(10):e145346.
6.
AvisarI, GatonDD, DaniaH, et al.The prevalence of polycystic ovary syndrome in women with idiopathic intracranial hypertension. Scientifica (Cairo), 2012; 2012:708042.
7.
TanMG, WorleyB, KimWB, et al.Drug-induced intracranial hypertension: A systematic review and critical assessment of drug-induced causes. Am J Clin Dermatol, 2020; 21:163–172.
8.
FriedmanD, DigreK, LiuG, eds. Diagnostic Criteria for the Pseudotumor Cerebri Syndrome in Adults and Children. Cephalalgia; Sage Publications Ltd.: England; 2013.
9.
BradyT, VeguntaS, CrumAV, et al.Interdisciplinary protocol for the management of vision-threatening papilledema. J Neuro Ophthalmol, 2022; 42(4):495–501.
10.
SinaF, RazmehS, HabibzadehN, et al.Migraine headache in patients with idiopathic intracranial hypertension. Neurol Int, 2017; 9(3):7280.